Evicenter
MarkdownMedical informationP&T meetings
Obefazimod (ABX464)

Ulcerative colitis

Manufacturer
Abivax
Launch
Not announced
Last updated
173 sources

Product information and disease descriptionProduct descriptionProduct informationDrug/Drug, drug/disease interactions

Effects of Obefazimod on other drugs

6 evidence topics · 6 sources

Caffeine, a CYP1A2 substrate: caffeine exposure with single and repeated obefazimod doses (Part A)
ParameterDay 1, caffeine 50 mg aloneDay 4, caffeine with obefazimod 50 mgDay 17, caffeine with obefazimod after 14 days of daily dosing
Participants analyzed“22”“22”“22”
Caffeine Cmax, ng/mL, mean (SD)“931(285)”“930(278)”“564(242)”
Caffeine AUC, h*ng/mL, mean (SD)“7420(4760)”“5460(2740)”“1560(719)”